The Conversation (0)
Adeona Pharmaceuticals, Inc., (AMEX:AEN) announced five scientific publications on the role of copper toxicity and zinc deficiency in Alzheimer’s disease and cognitive decline. The author of all these publications is Adeona’s scientific founder and consultant, George J. Brewer, M.D., the Morton S. and Henrietta Sellner Emeritus Professor of Human Genetics and Internal Medicine at the […]
Adeona Pharmaceuticals, Inc., (AMEX:AEN) announced five scientific publications on the role of copper toxicity and zinc deficiency in Alzheimer’s disease and cognitive decline. The author of all these publications is Adeona’s scientific founder and consultant, George J. Brewer, M.D., the Morton S. and Henrietta Sellner Emeritus Professor of Human Genetics and Internal Medicine at the University of Michigan.
George J. Brewer, M.D., Adeona’s scientific founder and consultant, remarked, “We are starting to build the peer-reviewed scientific literature that supports the hypothesis that copper toxicity and zinc deficiency is a hallmark of Alzheimer’s disease and cognitive decline. With that scientific infrastructure in place, I believe that high dose oral zinc administration should prove to have a vital therapeutic role in these disease conditions.”
For the full story, click here.